The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
PubMed
* PubMed Citation

Am J Psychiatry 1987; 144:1253-1262
Copyright © 1987 by American Psychiatric Association


SPECIAL ARTICLES

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry


The dexamethasone suppression test (DST) has had unprecedented evaluation among biological tests proposed for clinical use in psychiatry. It is hypothesized to reflect pathophysiologic changes at the CNS level. The sensitivity of the DST (rate of a positive outcome, or nonsuppression of cortisol) in major depression is modest (about 40%- 50%) but is higher (about 60%-70%) in very severe, especially psychotic, affective disorders, including major depression with psychotic as well as melancholic features, mania, and schizoaffective disorder. The specificity (true negative outcome) of the DST in normal control subjects is above 90%, but it varies from less than 70% to more than 90% in psychiatric conditions that often need to be separated from major affective disorders. In dementia the specificity is even lower. In addition, a number of medical conditions, including severe weight loss and use of alcohol and certain other drugs (barbiturates, anticonvulsants, and others), can produce false positive results. Positive initial DST status in major depression does not add significantly to the likelihood of antidepressant response, and a negative test is not an indication for withholding antidepressant treatment. Some recent data suggest that DST-positive depressions (cortisol nonsuppression) are less likely than DST-negative cases (cortisol suppression) to respond to a placebo. If this is confirmed, it would increase the real magnitude of the difference in treatment response between DST-positive and DST-negative depressed patients. Failure to convert to normal suppression of cortisol with apparent recovery from depression suggests an increased risk for relapse into depression or suicidal behavior. Although the clinical utility of the DST as currently understood is limited, in certain specific situations its thoughtful use may aid clinical decision making. The association of an abnormal test result with major affective disorders encourages continued research on the DST.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. P. Boyle, J. A. Brewer, M. Funatsu, D. F. Wozniak, J. Z. Tsien, Y. Izumi, and L. J. Muglia
Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior
PNAS, January 11, 2005; 102(2): 473 - 478.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. Grossman, R. Yehuda, A. New, J. Schmeidler, J. Silverman, V. Mitropoulou, N. Sta. Maria, J. Golier, and L. Siever
Dexamethasone Suppression Test Findings in Subjects With Personality Disorders: Associations With Posttraumatic Stress Disorder and Major Depression
Am J Psychiatry, July 1, 2003; 160(7): 1291 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Brooke, R. Chan, S. Howard, and R. Sapolsky
Endocrine modulation of the neurotoxicity of gp120: Implications for AIDS-related dementia complex
PNAS, August 19, 1997; 94(17): 9457 - 9462.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Deuschle, U. Schweiger, B. Weber, U. Gotthardt, A. Korner, J. Schmider, H. Standhardt, C.-H. Lammers, and I. Heuser
Diurnal Activity and Pulsatility of the Hypothalamus-Pituitary-Adrenal System in Male Depressed Patients and Healthy Controls
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 234 - 238.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Michels and P. M. Marzuk
Progress in Psychiatry- First of Two Parts
N. Engl. J. Med., August 19, 1993; 329(8): 552 - 560.
[Full Text]


Home page
J Geriatr Psychiatry NeurolHome page
S. Skare, B. Pew, and M. Dysken
The Dexamethasone Suppression Test in Dementia: A Review of the Literature
J Geriatr Psychiatry Neurol, July 1, 1990; 3(3): 124 - 138.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1987 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org